BioInvent International Balance Sheet Health
Financial Health criteria checks 6/6
BioInvent International has a total shareholder equity of SEK1.2B and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK1.3B and SEK96.0M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr1.06b |
| Equity | kr1.23b |
| Total liabilities | kr95.99m |
| Total assets | kr1.33b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BIX0's short term assets (SEK1.1B) exceed its short term liabilities (SEK83.5M).
Long Term Liabilities: BIX0's short term assets (SEK1.1B) exceed its long term liabilities (SEK12.5M).
Debt to Equity History and Analysis
Debt Level: BIX0 is debt free.
Reducing Debt: BIX0 has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BIX0 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: BIX0 has sufficient cash runway for 2.8 years if free cash flow continues to reduce at historical rates of 13.1% each year.